Home | NRI | Business Associates | Knowledge Bank | Careers | Back Office | Contact Us
 

Get Quotes
Company Background
Board Of Directors
Balance Sheet
Profit & Loss Accounts
Quarterly Results
Key Financial Ratios
Share Price
Charts
 
 
Profit and Loss
Alivus Life Sciences Ltd
    Industry   : Pharmaceuticals - Indian - Bulk Drugs & Formln  Chairman  : HIREN KARSANBHAI PATEL
    Home        : Indian Private  Book Value: 245.7876662
    BSE Code  : 543322  Market Cap: 11053.59
    NSE Code  : ALIVUS  P / E              : 20.84 

Change Company :
(Rs in Cr.)
Profit and Loss
ParticularsMar 2025Mar 2024Mar 2023Mar 2022Mar 2021
Sales Turnover & Other Income 2421.452295.252190.182137.911885.98
Excise Duty0.000.000.000.000.00
Total Income2394.102351.822274.622096.591956.68
Raw Materials 1010.091025.211068.56977.96948.17
Stock Adjustments -27.3556.5784.44-41.3270.70
Other Manufacturing Expenses 177.41163.64137.17124.04107.32
Power & Fuel Cost117.24112.46115.60100.9274.19
Employee Cost 251.70258.16180.18168.72149.13
Selling and Administration Expenses 83.5864.1265.4748.6448.50
Miscellaneous Expenses 36.9341.9736.3945.5637.49
Less: Preoperative Expenditure Capitalised0.000.000.000.000.00
Profit before Interest, Depreciation & Tax717.15686.29671.25630.76591.88
Interest & Financial Charges 2.411.550.5527.9687.55
Profit before Depreciation & Tax714.74684.74670.70602.80504.33
Depreciation60.6153.4542.0937.8833.39
Profit Before Tax654.13631.29628.61564.92470.94
Tax168.50160.40161.65146.20119.36
Profit After Tax485.63470.89466.96418.72351.58
Adjustment below Net Profit -0.25-5.46-0.29-19.50-0.53
P & L Balance brought forward1291.801102.061021.35750.79399.73
Appropriations 0.00275.69385.96128.650.00
P & L Bal. carried down1777.181291.801102.061021.35750.79
Equity Dividend0.00275.69385.96128.650.00
Preference Dividend0.000.000.000.000.00
Corporate Dividend Tax0.000.000.000.000.00
Equity Dividend (%)250.001125.002100.001050.000.00
Earning Per Share (Rs.)39.6338.4338.1134.17358.76
Book Value229.92190.35174.51167.66768.11
Extraordinary Items 4.30-0.53-0.41-0.55-0.44
Top
BSE Disclaimer     |     Disclaimer     |     Privacy Statement     |     Terms of Use     |     Feedback     |    Sitemap     |    Downloads    |     Client Bank Details
Useful Links   | Risk Disclosure   | Rules and Regulations   |   Investor Charter / Complaints   |   Smart ODR   |   Scores   |   Attention Investors   | Audit Compliance Report   | RA – Annual Compliance Audit Report 2024-25   |

SEBI Saa₹thi Mobile App/SEBI Investor Website  

SSJ FINANCE & SECURITIES PRIVATE LIMITED:
1st Floor, Merchant Chamber, Opp. Patkar Hall, 41, New Marine Lines, Mumbai – 400 020
SEBI Regn. Number: INZ000178436 | CDSL: IN-DP-109-2015 | ARN: 40860 | CIN: U67120MH1996PTC104822
SSJ COMMODITIES PRIVATE LIMITED:
SEBI Regn. Number: INZ000013439 | CIN: U51909MH2003PTC140481|Research Analyst SEBI Reg. No.INH000001527
2006-07 © SSJ Finance & Securities Pvt. Ltd. All Rights Reserved Developed & Maintained By C-MOTS Infotech(ISO 9001:2015 certified)
Content powered by Capital Market Charts are powered by TradingView